aluates Reports

$ 0.0

Automative

Global Milbexime Anthelmintic Market Research Report 2026

Published Date: 2026-01-08

Report Code: QYRE-Auto-27O17782

Global Milbexime Anthelmintic Market Research Report 2024

BUY CHAPTERS

Global Milbexime Anthelmintic Market Research Report 2026

Code: QYRE-Auto-27O17782

Report

2026-01-08

Pages:108

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Elanco Animal Health

Boehringer Ingelheim Animal Health

Merck Animal Health

Virbac SA

Krka

Zhejiang Hisun Pharmaceutical Co Ltd

Milbexime Anthelmintic Market Size

The global Milbexime Anthelmintic market was valued at US$ 102 million in 2025 and is anticipated to reach US$ 152 million by 2032, at a CAGR of 5.9% from 2026 to 2032.

Milbexime Anthelmintic Market

The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Milbexime Anthelmintic competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.

Milbemycin is a broad-spectrum veterinary anthelmintic with milbemycin as its main active ingredient. It belongs to the macrolide class of antiparasitic drugs and is primarily used for the prevention and treatment of internal parasites in companion animals such as dogs and cats. This type of drug works by acting on the nerve and muscle cells of the parasite, interfering with nerve signal transmission, causing paralysis and ultimately death. It is effective against roundworms, hookworms, whipworms, and heartworm larvae. Milbemycin is stable in its efficacy and has a high safety profile, commonly used in routine deworming programs for pets, and is an important component of modern pet medical and preventative medication systems. The upstream supplier is the milbemycin raw material, with major suppliers including Livzon Pharmaceutical and Hisun Pharmaceutical. The price of milbemycin varies significantly depending on the milbemycin content; common strengths include 1.8 mg, 2.3 mg, 4.5 mg, 15 mg, and 27.5 mg.

Against the backdrop of the continued expansion of the global pet economy and the continuous improvement of veterinary medical standardization, parasite control is shifting from "occasional treatment" to "long-term, systematic prevention." In this transformation, deworming medications are no longer just single-function products, but rather a crucial foundational component of modern pet health management systems. As one of the core products in this system, milbemectin is gradually establishing its long-term market position in the companion animal deworming field, with its industrial value and market potential becoming increasingly prominent.

Mirbectin belongs to the macrolide class of antiparasitic drugs and is primarily used for the prevention and treatment of internal parasites in companion animals such as dogs and cats. With its broad spectrum of action, clear mechanism of action, and high safety profile, milbemectin is widely used in regular pet deworming programs. It not only effectively prevents and treats various common intestinal parasites but also plays a vital role in key application scenarios such as heartworm larval prevention, becoming one of the "basic drugs" in the pet deworming medication system.

From the demand side, the growth of milbemectin deworming medication is closely related to the increase in the global pet population, the upgrading of pet ownership concepts, and the popularization of veterinary medical care. As pets are increasingly regarded as family members, pet owners are paying significantly more attention to health management, and regular deworming has become a standardized pet-keeping practice. This trend is already highly prevalent in mature markets such as Europe, the United States, and Japan, and is accelerating its penetration in emerging markets such as China, Southeast Asia, and Latin America, providing a continuous and stable demand foundation for the milbemectin deworming medication market.

From a product structure perspective, milbemectin deworming medication often exists in single-ingredient or compound formulations, and is used in combination with other deworming ingredients to improve coverage and ease of use. This trend towards compound and solution-based development means that milbemectin is no longer just a single drug ingredient, but is integrated into a complete pet parasite prevention and control solution, effectively enhancing its market stickiness and application depth.

In terms of the competitive landscape, the milbemectin deworming medication market exhibits a characteristic of "coexistence of branded formulations and generic products." International veterinary drug companies hold an advantage in high-end and mature markets due to their brands, distribution channels, and long-term clinical application experience. Meanwhile, with the improvement of raw material supply systems and the maturity of formulation technologies, companies with compliance capabilities and cost advantages are gradually entering the market, driving product coverage across more price ranges and regional markets. This structure allows the milbemime anthelmintic market to maintain stable growth while also possessing a certain degree of competitive vitality.

From a supply chain perspective, milbemime anthelmintics are highly dependent on the quality and stable supply of upstream raw materials. The purity, impurity control, and batch consistency of raw materials directly affect the safety and efficacy of downstream formulations. As veterinary drug regulatory requirements continue to tighten in various countries, formulation companies are paying increasing attention to the compliance and traceability of raw material sources, which is objectively driving the milbemime anthelmintic supply chain towards a quality-oriented and long-term cooperation model.

Looking ahead, the development of the milbemime anthelmintic market will focus more on preventative use, compound formulations, and standardized application. As pet healthcare shifts from a "treatment-oriented" to a "prevention-oriented" approach, the frequency of deworming medication use and the population it covers are expected to continue to expand; combination formulations and convenient administration methods will further improve user compliance; and with the continuous improvement of regulations and clinical standards, the importance of safety and long-term use data will also continue to increase.

This report delivers a comprehensive overview of the global Milbexime Anthelmintic market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Milbexime Anthelmintic. The Milbexime Anthelmintic market size, estimates, and forecasts are provided in terms of sales volume (K Units) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.

The report segments the global Milbexime Anthelmintic market comprehensively. Regional market sizes by Type, by Application, by Form, and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.

This report will assist Milbexime Anthelmintic manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.

Market Segmentation

Scope of Milbexime Anthelmintic Market Report

Report Metric	Details
Report Name	Milbexime Anthelmintic Market
Accounted market size in 2025	US$ 102 in million
Forecasted market size in 2032	US$ 152 million
CAGR	5.9%
Base Year	2025
Forecasted years	2026 - 2032
Segment by Type	Milbexime + Afrana Milbexime + Praziquantel Others
Segment by Form	Oral Tablets Oral Granules
Segment by Function	Regular Preventative Treatment Therapeutic Treatment
by Application	Cat Dog Other
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Elanco Animal Health, Boehringer Ingelheim Animal Health, Merck Animal Health, VIRBAC SA, Krka, Zhejiang Hisun Pharmaceutical Co., Ltd
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, by Form, etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for Milbexime Anthelmintic manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
Chapter 3: Examines Milbexime Anthelmintic sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 9: Summarizes the key findings and conclusions of the report.

FAQ for this report

How fast is Milbexime Anthelmintic Market growing?

Ans: The Milbexime Anthelmintic Market witnessing a CAGR of 5.9% during the forecast period 2026-2032.

What is the Milbexime Anthelmintic Market size in 2032?

Ans: The Milbexime Anthelmintic Market size in 2032 will be US$ 152 million.

Who are the main players in the Milbexime Anthelmintic Market report?

Ans: The main players in the Milbexime Anthelmintic Market are Elanco Animal Health, Boehringer Ingelheim Animal Health, Merck Animal Health, VIRBAC SA, Krka, Zhejiang Hisun Pharmaceutical Co., Ltd

What are the Application segmentation covered in the Milbexime Anthelmintic Market report?

Ans: The Applications covered in the Milbexime Anthelmintic Market report are Cat, Dog, Other

What are the Type segmentation covered in the Milbexime Anthelmintic Market report?

Ans: The Types covered in the Milbexime Anthelmintic Market report are Milbexime + Afrana, Milbexime + Praziquantel, Others

1 Milbexime Anthelmintic Market Overview

1.1 Product Definition

1.2 Milbexime Anthelmintic by Type

1.2.1 Global Milbexime Anthelmintic Market Value by Type: 2025 vs 2032

1.2.2 Milbexime + Afrana

1.2.3 Milbexime + Praziquantel

1.2.4 Others

1.3 Milbexime Anthelmintic by Form

1.3.1 Global Milbexime Anthelmintic Market Value by Form: 2025 vs 2032

1.3.2 Oral Tablets

1.3.3 Oral Granules

1.4 Milbexime Anthelmintic by Function

1.4.1 Global Milbexime Anthelmintic Market Value by Function: 2025 vs 2032

1.4.2 Regular Preventative Treatment

1.4.3 Therapeutic Treatment

1.5 Milbexime Anthelmintic by Application

1.5.1 Global Milbexime Anthelmintic Market Value by Application: 2025 vs 2032

1.5.2 Cat

1.5.3 Dog

1.5.4 Other

1.6 Global Milbexime Anthelmintic Market Size Estimates and Forecasts

1.6.1 Global Milbexime Anthelmintic Revenue 2021–2032

1.6.2 Global Milbexime Anthelmintic Sales 2021–2032

1.6.3 Global Milbexime Anthelmintic Market Average Price (2021–2032)

1.7 Assumptions and Limitations

2 Milbexime Anthelmintic Market Competition by Manufacturers

2.1 Global Milbexime Anthelmintic Sales Market Share by Manufacturers (2021–2026)

2.2 Global Milbexime Anthelmintic Revenue Market Share by Manufacturers (2021–2026)

2.3 Global Milbexime Anthelmintic Average Price by Manufacturers (2021–2026)

2.4 Global Key Players of Milbexime Anthelmintic, Industry Ranking, 2023 vs 2024 vs 2025

2.5 Global Key Manufacturers of Milbexime Anthelmintic, Manufacturing Sites and Headquarters

2.6 Global Key Manufacturers of Milbexime Anthelmintic, Product Types and Applications

2.7 Global Key Manufacturers of Milbexime Anthelmintic, Date of Entry into the Industry

2.8 Global Milbexime Anthelmintic Market Competitive Situation and Trends

2.8.1 Global Milbexime Anthelmintic Market Concentration Rate

2.8.2 The Top 5 and Top 10 Global Milbexime Anthelmintic Players Market Share by Revenue

2.8.3 Global Milbexime Anthelmintic Market Share by Company Tier (Tier 1, Tier 2, Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global Milbexime Anthelmintic Market Scenario by Region

3.1 Global Milbexime Anthelmintic Market Size by Region: 2021 vs 2025 vs 2032

3.2 Global Milbexime Anthelmintic Sales by Region: 2021–2032

3.2.1 Global Milbexime Anthelmintic Sales by Region: 2021–2026

3.2.2 Global Milbexime Anthelmintic Sales by Region: 2027–2032

3.3 Global Milbexime Anthelmintic Revenue by Region: 2021–2032

3.3.1 Global Milbexime Anthelmintic Revenue by Region: 2021–2026

3.3.2 Global Milbexime Anthelmintic Revenue by Region: 2027–2032

3.4 North America Milbexime Anthelmintic Market Facts & Figures by Country

3.4.1 North America Milbexime Anthelmintic Market Size by Country: 2021 vs 2025 vs 2032

3.4.2 North America Milbexime Anthelmintic Sales by Country (2021–2032)

3.4.3 North America Milbexime Anthelmintic Revenue by Country (2021–2032)

3.4.4 United States

3.4.5 Canada

3.5 Europe Milbexime Anthelmintic Market Facts & Figures by Country

3.5.1 Europe Milbexime Anthelmintic Market Size by Country: 2021 vs 2025 vs 2032

3.5.2 Europe Milbexime Anthelmintic Sales by Country (2021–2032)

3.5.3 Europe Milbexime Anthelmintic Revenue by Country (2021–2032)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Milbexime Anthelmintic Market Facts & Figures by Region

3.6.1 Asia Pacific Milbexime Anthelmintic Market Size by Region: 2021 vs 2025 vs 2032

3.6.2 Asia Pacific Milbexime Anthelmintic Sales by Region (2021–2032)

3.6.3 Asia Pacific Milbexime Anthelmintic Revenue by Region (2021–2032)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Southeast Asia

3.7 Latin America Milbexime Anthelmintic Market Facts & Figures by Country

3.7.1 Latin America Milbexime Anthelmintic Market Size by Country: 2021 vs 2025 vs 2032

3.7.2 Latin America Milbexime Anthelmintic Sales by Country (2021–2032)

3.7.3 Latin America Milbexime Anthelmintic Revenue by Country (2021–2032)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.7.7 Colombia

3.8 Middle East and Africa Milbexime Anthelmintic Market Facts & Figures by Country

3.8.1 Middle East and Africa Milbexime Anthelmintic Market Size by Country: 2021 vs 2025 vs 2032

3.8.2 Middle East and Africa Milbexime Anthelmintic Sales by Country (2021–2032)

3.8.3 Middle East and Africa Milbexime Anthelmintic Revenue by Country (2021–2032)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global Milbexime Anthelmintic Sales by Type (2021–2032)

4.1.1 Global Milbexime Anthelmintic Sales by Type (2021–2026)

4.1.2 Global Milbexime Anthelmintic Sales by Type (2027–2032)

4.1.3 Global Milbexime Anthelmintic Sales Market Share by Type (2021–2032)

4.2 Global Milbexime Anthelmintic Revenue by Type (2021–2032)

4.2.1 Global Milbexime Anthelmintic Revenue by Type (2021–2026)

4.2.2 Global Milbexime Anthelmintic Revenue by Type (2027–2032)

4.2.3 Global Milbexime Anthelmintic Revenue Market Share by Type (2021–2032)

4.3 Global Milbexime Anthelmintic Price by Type (2021–2032)

5 Segment by Application

5.1 Global Milbexime Anthelmintic Sales by Application (2021–2032)

5.1.1 Global Milbexime Anthelmintic Sales by Application (2021–2026)

5.1.2 Global Milbexime Anthelmintic Sales by Application (2027–2032)

5.1.3 Global Milbexime Anthelmintic Sales Market Share by Application (2021–2032)

5.2 Global Milbexime Anthelmintic Revenue by Application (2021–2032)

5.2.1 Global Milbexime Anthelmintic Revenue by Application (2021–2026)

5.2.2 Global Milbexime Anthelmintic Revenue by Application (2027–2032)

5.2.3 Global Milbexime Anthelmintic Revenue Market Share by Application (2021–2032)

5.3 Global Milbexime Anthelmintic Price by Application (2021–2032)

6 Key Companies Profiled

6.1 Elanco Animal Health

6.1.1 Elanco Animal Health Company Information

6.1.2 Elanco Animal Health Description and Business Overview

6.1.3 Elanco Animal Health Milbexime Anthelmintic Sales, Revenue, and Gross Margin (2021–2026)

6.1.4 Elanco Animal Health Milbexime Anthelmintic Product Portfolio

6.1.5 Elanco Animal Health Recent Developments/Updates

6.2 Boehringer Ingelheim Animal Health

6.2.1 Boehringer Ingelheim Animal Health Company Information

6.2.2 Boehringer Ingelheim Animal Health Description and Business Overview

6.2.3 Boehringer Ingelheim Animal Health Milbexime Anthelmintic Sales, Revenue, and Gross Margin (2021–2026)

6.2.4 Boehringer Ingelheim Animal Health Milbexime Anthelmintic Product Portfolio

6.2.5 Boehringer Ingelheim Animal Health Recent Developments/Updates

6.3 Merck Animal Health

6.3.1 Merck Animal Health Company Information

6.3.2 Merck Animal Health Description and Business Overview

6.3.3 Merck Animal Health Milbexime Anthelmintic Sales, Revenue, and Gross Margin (2021–2026)

6.3.4 Merck Animal Health Milbexime Anthelmintic Product Portfolio

6.3.5 Merck Animal Health Recent Developments/Updates

6.4 VIRBAC SA

6.4.1 VIRBAC SA Company Information

6.4.2 VIRBAC SA Description and Business Overview

6.4.3 VIRBAC SA Milbexime Anthelmintic Sales, Revenue, and Gross Margin (2021–2026)

6.4.4 VIRBAC SA Milbexime Anthelmintic Product Portfolio

6.4.5 VIRBAC SA Recent Developments/Updates

6.5 Krka

6.5.1 Krka Company Information

6.5.2 Krka Description and Business Overview

6.5.3 Krka Milbexime Anthelmintic Sales, Revenue, and Gross Margin (2021–2026)

6.5.4 Krka Milbexime Anthelmintic Product Portfolio

6.5.5 Krka Recent Developments/Updates

6.6 Zhejiang Hisun Pharmaceutical Co., Ltd

6.6.1 Zhejiang Hisun Pharmaceutical Co., Ltd Company Information

6.6.2 Zhejiang Hisun Pharmaceutical Co., Ltd Description and Business Overview

6.6.3 Zhejiang Hisun Pharmaceutical Co., Ltd Milbexime Anthelmintic Sales, Revenue, and Gross Margin (2021–2026)

6.6.4 Zhejiang Hisun Pharmaceutical Co., Ltd Milbexime Anthelmintic Product Portfolio

6.6.5 Zhejiang Hisun Pharmaceutical Co., Ltd Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Milbexime Anthelmintic Industry Chain Analysis

7.2 Milbexime Anthelmintic Raw Material Supply Analysis

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Milbexime Anthelmintic Production Mode & Process Analysis

7.4 Milbexime Anthelmintic Sales and Marketing

7.4.1 Milbexime Anthelmintic Sales Channels

7.4.2 Milbexime Anthelmintic Distributors

7.5 Milbexime Anthelmintic Customer Analysis

8 Milbexime Anthelmintic Market Dynamics

8.1 Milbexime Anthelmintic Industry Trends

8.2 Milbexime Anthelmintic Market Drivers

8.3 Milbexime Anthelmintic Market Challenges

8.4 Milbexime Anthelmintic Market Restraints

8.5 Impact of U.S. Tariffs

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Elanco Animal Health

Boehringer Ingelheim Animal Health

Merck Animal Health

Virbac SA

Krka

Zhejiang Hisun Pharmaceutical Co Ltd

List of Tables

Table 1. Global Milbexime Anthelmintic Market Value by Type (US$ Million), 2025 vs 2032

Table 2. Global Milbexime Anthelmintic Market Value by Form (US$ Million), 2025 vs 2032

Table 3. Global Milbexime Anthelmintic Market Value by Function (US$ Million), 2025 vs 2032

Table 4. Global Milbexime Anthelmintic Market Value by Application (US$ Million), 2025 vs 2032

Table 5. Global Milbexime Anthelmintic Market Competitive Situation by Manufacturers in 2025

Table 6. Global Milbexime Anthelmintic Sales (K Units) of Key Manufacturers (2021–2026)

Table 7. Global Milbexime Anthelmintic Sales Market Share by Manufacturers (2021–2026)

Table 8. Global Milbexime Anthelmintic Revenue (US$ Million) by Manufacturers (2021–2026)

Table 9. Global Milbexime Anthelmintic Revenue Share by Manufacturers (2021–2026)

Table 10. Global Market Milbexime Anthelmintic Average Price (US$/Unit) of Key Manufacturers (2021–2026)

Table 11. Global Key Players of Milbexime Anthelmintic, Industry Ranking, 2023 vs 2024 vs 2025

Table 12. Global Key Manufacturers of Milbexime Anthelmintic, Manufacturing Sites and Headquarters

Table 13. Global Key Manufacturers of Milbexime Anthelmintic, Product Types and Applications

Table 14. Global Key Manufacturers of Milbexime Anthelmintic, Date of Entry into the Industry

Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 16. Global Milbexime Anthelmintic Companies by Tier (Tier 1, Tier 2, Tier 3), based on Milbexime Anthelmintic Revenue, 2025

Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 18. Global Milbexime Anthelmintic Market Size by Region (US$ Million): 2021 vs 2025 vs 2032

Table 19. Global Milbexime Anthelmintic Sales by Region (K Units), 2021–2026

Table 20. Global Milbexime Anthelmintic Sales Market Share by Region (2021–2026)

Table 21. Global Milbexime Anthelmintic Sales by Region (K Units), 2027–2032

Table 22. Global Milbexime Anthelmintic Sales Market Share by Region (2027–2032)

Table 23. Global Milbexime Anthelmintic Revenue by Region (US$ Million), 2021–2026

Table 24. Global Milbexime Anthelmintic Revenue Market Share by Region (2021–2026)

Table 25. Global Milbexime Anthelmintic Revenue by Region (US$ Million), 2027–2032

Table 26. Global Milbexime Anthelmintic Revenue Market Share by Region (2027–2032)

Table 27. North America Milbexime Anthelmintic Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)

Table 28. North America Milbexime Anthelmintic Sales by Country (K Units), 2021–2026

Table 29. North America Milbexime Anthelmintic Sales by Country (K Units), 2027–2032

Table 30. North America Milbexime Anthelmintic Revenue by Country (US$ Million), 2021–2026

Table 31. North America Milbexime Anthelmintic Revenue by Country (US$ Million), 2027–2032

Table 32. Europe Milbexime Anthelmintic Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)

Table 33. Europe Milbexime Anthelmintic Sales by Country (K Units), 2021–2026

Table 34. Europe Milbexime Anthelmintic Sales by Country (K Units), 2027–2032

Table 35. Europe Milbexime Anthelmintic Revenue by Country (US$ Million), 2021–2026

Table 36. Europe Milbexime Anthelmintic Revenue by Country (US$ Million), 2027–2032

Table 37. Asia Pacific Milbexime Anthelmintic Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)

Table 38. Asia Pacific Milbexime Anthelmintic Sales by Region (K Units), 2021–2026

Table 39. Asia Pacific Milbexime Anthelmintic Sales by Region (K Units), 2027–2032

Table 40. Asia Pacific Milbexime Anthelmintic Revenue by Region (US$ Million), 2021–2026

Table 41. Asia Pacific Milbexime Anthelmintic Revenue by Region (US$ Million), 2027–2032

Table 42. Latin America Milbexime Anthelmintic Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)

Table 43. Latin America Milbexime Anthelmintic Sales by Country (K Units), 2021–2026

Table 44. Latin America Milbexime Anthelmintic Sales by Country (K Units), 2027–2032

Table 45. Latin America Milbexime Anthelmintic Revenue by Country (US$ Million), 2021–2026

Table 46. Latin America Milbexime Anthelmintic Revenue by Country (US$ Million), 2027–2032

Table 47. Middle East and Africa Milbexime Anthelmintic Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)

Table 48. Middle East and Africa Milbexime Anthelmintic Sales by Country (K Units), 2021–2026

Table 49. Middle East and Africa Milbexime Anthelmintic Sales by Country (K Units), 2027–2032

Table 50. Middle East and Africa Milbexime Anthelmintic Revenue by Country (US$ Million), 2021–2026

Table 51. Middle East and Africa Milbexime Anthelmintic Revenue by Country (US$ Million), 2027–2032

Table 52. Global Milbexime Anthelmintic Sales (K Units) by Type (2021–2026)

Table 53. Global Milbexime Anthelmintic Sales (K Units) by Type (2027–2032)

Table 54. Global Milbexime Anthelmintic Sales Market Share by Type (2021–2026)

Table 55. Global Milbexime Anthelmintic Sales Market Share by Type (2027–2032)

Table 56. Global Milbexime Anthelmintic Revenue (US$ Million) by Type (2021–2026)

Table 57. Global Milbexime Anthelmintic Revenue (US$ Million) by Type (2027–2032)

Table 58. Global Milbexime Anthelmintic Revenue Market Share by Type (2021–2026)

Table 59. Global Milbexime Anthelmintic Revenue Market Share by Type (2027–2032)

Table 60. Global Milbexime Anthelmintic Price (US$/Unit) by Type (2021–2026)

Table 61. Global Milbexime Anthelmintic Price (US$/Unit) by Type (2027–2032)

Table 62. Global Milbexime Anthelmintic Sales (K Units) by Application (2021–2026)

Table 63. Global Milbexime Anthelmintic Sales (K Units) by Application (2027–2032)

Table 64. Global Milbexime Anthelmintic Sales Market Share by Application (2021–2026)

Table 65. Global Milbexime Anthelmintic Sales Market Share by Application (2027–2032)

Table 66. Global Milbexime Anthelmintic Revenue (US$ Million) by Application (2021–2026)

Table 67. Global Milbexime Anthelmintic Revenue (US$ Million) by Application (2027–2032)

Table 68. Global Milbexime Anthelmintic Revenue Market Share by Application (2021–2026)

Table 69. Global Milbexime Anthelmintic Revenue Market Share by Application (2027–2032)

Table 70. Global Milbexime Anthelmintic Price (US$/Unit) by Application (2021–2026)

Table 71. Global Milbexime Anthelmintic Price (US$/Unit) by Application (2027–2032)

Table 72. Elanco Animal Health Company Information

Table 73. Elanco Animal Health Description and Business Overview

Table 74. Elanco Animal Health Milbexime Anthelmintic Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

Table 75. Elanco Animal Health Milbexime Anthelmintic Product

Table 76. Elanco Animal Health Recent Developments/Updates

Table 77. Boehringer Ingelheim Animal Health Company Information

Table 78. Boehringer Ingelheim Animal Health Description and Business Overview

Table 79. Boehringer Ingelheim Animal Health Milbexime Anthelmintic Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

Table 80. Boehringer Ingelheim Animal Health Milbexime Anthelmintic Product

Table 81. Boehringer Ingelheim Animal Health Recent Developments/Updates

Table 82. Merck Animal Health Company Information

Table 83. Merck Animal Health Description and Business Overview

Table 84. Merck Animal Health Milbexime Anthelmintic Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

Table 85. Merck Animal Health Milbexime Anthelmintic Product

Table 86. Merck Animal Health Recent Developments/Updates

Table 87. VIRBAC SA Company Information

Table 88. VIRBAC SA Description and Business Overview

Table 89. VIRBAC SA Milbexime Anthelmintic Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

Table 90. VIRBAC SA Milbexime Anthelmintic Product

Table 91. VIRBAC SA Recent Developments/Updates

Table 92. Krka Company Information

Table 93. Krka Description and Business Overview

Table 94. Krka Milbexime Anthelmintic Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

Table 95. Krka Milbexime Anthelmintic Product

Table 96. Krka Recent Developments/Updates

Table 97. Zhejiang Hisun Pharmaceutical Co., Ltd Company Information

Table 98. Zhejiang Hisun Pharmaceutical Co., Ltd Description and Business Overview

Table 99. Zhejiang Hisun Pharmaceutical Co., Ltd Milbexime Anthelmintic Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

Table 100. Zhejiang Hisun Pharmaceutical Co., Ltd Milbexime Anthelmintic Product

Table 101. Zhejiang Hisun Pharmaceutical Co., Ltd Recent Developments/Updates

Table 102. Key Raw Materials Lists

Table 103. Raw Materials Key Suppliers Lists

Table 104. Milbexime Anthelmintic Distributors List

Table 105. Milbexime Anthelmintic Customers List

Table 106. Milbexime Anthelmintic Market Trends

Table 107. Milbexime Anthelmintic Market Drivers

Table 108. Milbexime Anthelmintic Market Challenges

Table 109. Milbexime Anthelmintic Market Restraints

Table 110. Research Programs/Design for This Report

Table 111. Key Data Information from Secondary Sources

Table 112. Key Data Information from Primary Sources

Table 113. Authors List of This Report

List of Figures

Figure 1. Product Picture of Milbexime Anthelmintic

Figure 2. Global Milbexime Anthelmintic Market Value by Type (US$ Million), 2021–2032

Figure 3. Global Milbexime Anthelmintic Market Share by Type: 2025 & 2032

Figure 4. Milbexime + Afrana Product Picture

Figure 5. Milbexime + Praziquantel Product Picture

Figure 6. Others Product Picture

Figure 7. Global Milbexime Anthelmintic Market Value by Form (US$ Million), 2021–2032

Figure 8. Global Milbexime Anthelmintic Market Share by Form: 2025 vs 2032

Figure 9. Oral Tablets Product Picture

Figure 10. Oral Granules Product Picture

Figure 11. Global Milbexime Anthelmintic Market Value by Function (US$ Million), 2021–2032

Figure 12. Global Milbexime Anthelmintic Market Share by Function: 2025 vs 2032

Figure 13. Regular Preventative Treatment Product Picture

Figure 14. Therapeutic Treatment Product Picture

Figure 15. Global Milbexime Anthelmintic Market Value by Application (US$ Million), 2021–2032

Figure 16. Global Milbexime Anthelmintic Market Share by Application: 2025 & 2032

Figure 17. Cat

Figure 18. Dog

Figure 19. Other

Figure 20. Global Milbexime Anthelmintic Revenue, (US$ Million), 2021 vs 2025 vs 2032

Figure 21. Global Milbexime Anthelmintic Market Size (US$ Million), 2021–2032

Figure 22. Global Milbexime Anthelmintic Sales (K Units), 2021–2032

Figure 23. Global Milbexime Anthelmintic Average Price (US$/Unit), 2021–2032

Figure 24. Milbexime Anthelmintic Report Years Considered

Figure 25. Milbexime Anthelmintic Sales Share by Manufacturers in 2025

Figure 26. Global Milbexime Anthelmintic Revenue Share by Manufacturers in 2025

Figure 27. Top 5 and Top 10 Global Milbexime Anthelmintic Players: Market Share by Revenue in Milbexime Anthelmintic in 2025

Figure 28. Milbexime Anthelmintic Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025

Figure 29. Global Milbexime Anthelmintic Market Size by Region (US$ Million): 2021 vs 2025 vs 2032

Figure 30. North America Milbexime Anthelmintic Sales Market Share by Country (2021–2032)

Figure 31. North America Milbexime Anthelmintic Revenue Market Share by Country (2021–2032)

Figure 32. United States Milbexime Anthelmintic Revenue Growth Rate (US$ Million), 2021–2032

Figure 33. Canada Milbexime Anthelmintic Revenue Growth Rate (US$ Million), 2021–2032

Figure 34. Europe Milbexime Anthelmintic Sales Market Share by Country (2021–2032)

Figure 35. Europe Milbexime Anthelmintic Revenue Market Share by Country (2021–2032)

Figure 36. Germany Milbexime Anthelmintic Revenue Growth Rate (US$ Million), 2021–2032

Figure 37. France Milbexime Anthelmintic Revenue Growth Rate (US$ Million), 2021–2032

Figure 38. U.K. Milbexime Anthelmintic Revenue Growth Rate (US$ Million), 2021–2032

Figure 39. Italy Milbexime Anthelmintic Revenue Growth Rate (US$ Million), 2021–2032

Figure 40. Russia Milbexime Anthelmintic Revenue Growth Rate (US$ Million), 2021–2032

Figure 41. Asia Pacific Milbexime Anthelmintic Sales Market Share by Region (2021–2032)

Figure 42. Asia Pacific Milbexime Anthelmintic Revenue Market Share by Region (2021–2032)

Figure 43. China Milbexime Anthelmintic Revenue Growth Rate (US$ Million), 2021–2032

Figure 44. Japan Milbexime Anthelmintic Revenue Growth Rate (US$ Million), 2021–2032

Figure 45. South Korea Milbexime Anthelmintic Revenue Growth Rate (US$ Million), 2021–2032

Figure 46. India Milbexime Anthelmintic Revenue Growth Rate (US$ Million), 2021–2032

Figure 47. Australia Milbexime Anthelmintic Revenue Growth Rate (US$ Million), 2021–2032

Figure 48. China Taiwan Milbexime Anthelmintic Revenue Growth Rate (US$ Million), 2021–2032

Figure 49. Southeast Asia Milbexime Anthelmintic Revenue Growth Rate (US$ Million), 2021–2032

Figure 50. Latin America Milbexime Anthelmintic Sales Market Share by Country (2021–2032)

Figure 51. Latin America Milbexime Anthelmintic Revenue Market Share by Country (2021–2032)

Figure 52. Mexico Milbexime Anthelmintic Revenue Growth Rate (US$ Million), 2021–2032

Figure 53. Brazil Milbexime Anthelmintic Revenue Growth Rate (US$ Million), 2021–2032

Figure 54. Argentina Milbexime Anthelmintic Revenue Growth Rate (US$ Million), 2021–2032

Figure 55. Colombia Milbexime Anthelmintic Revenue Growth Rate (US$ Million), 2021–2032

Figure 56. Middle East and Africa Milbexime Anthelmintic Sales Market Share by Country (2021–2032)

Figure 57. Middle East and Africa Milbexime Anthelmintic Revenue Market Share by Country (2021–2032)

Figure 58. Turkey Milbexime Anthelmintic Revenue Growth Rate (US$ Million), 2021–2032

Figure 59. Saudi Arabia Milbexime Anthelmintic Revenue Growth Rate (US$ Million), 2021–2032

Figure 60. UAE Milbexime Anthelmintic Revenue Growth Rate (US$ Million), 2021–2032

Figure 61. Global Sales Market Share of Milbexime Anthelmintic by Type (2021–2032)

Figure 62. Global Revenue Market Share of Milbexime Anthelmintic by Type (2021–2032)

Figure 63. Global Milbexime Anthelmintic Price (US$/Unit) by Type (2021–2032)

Figure 64. Global Sales Market Share of Milbexime Anthelmintic by Application (2021–2032)

Figure 65. Global Revenue Market Share of Milbexime Anthelmintic by Application (2021–2032)

Figure 66. Global Milbexime Anthelmintic Price (US$/Unit) by Application (2021–2032)

Figure 67. Milbexime Anthelmintic Value Chain

Figure 68. Channels of Distribution (Direct Vs Distribution)

Figure 69. Bottom-up and Top-down Approaches for This Report

Figure 70. Data Triangulation

Figure 71. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic

$2900

Single User License

Multi User

Electronic

$4350

Multi User License

Enterprise License

Electronic

$5800

Enterprise License

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Flubendazole Market Research Report 2024

Global Antinematode Drugs Market Research Report 2024

Global γ Aminobutyric Acid Receptor Agonists Market Research Report 2025

Global Anti helminthic Drugs Market Research Report 2024

Global Moxidectin API Market Research Report 2024

Global Albendazole Tablets Market Research Report 2024

Global Mebendazole Market Research Report 2024

Neuromuscular Blocking Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global GABA γ aminobutyric acid Market Insights Forecast to 2030

Global Butylscopolamine Bromide Market Research Report 2024

Global Anthelmintic Drugs Market Research Report 2024

Global Companion Animal Anthelmintics Market Research Report 2024

Global Vermox Market Research Report 2024

Global Animal Internal Parasiticide Market Insights Forecast to 2030

Global Milbemycin Oxime API Market Research Report 2025

Albendazole Anthelmintic Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Injectable Anthelmintic Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Valbazen Anthelmintic Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Closantel Sodium Market Research Report 2024

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions